This disclosure relates to compounds of formula (I), which are modulators of STING. Also disclosed are pharmaceutical compositions comprising compounds of formula (I) and methods of using compounds of formula (I) in the treatment or prevention of diseases
-
Page/Page column 121
(2021/06/26)
NRF2 REGULATORS
Provided are aryl analogs,pharmaceutical compositions containing them and their use as NRF2 regulators.
-
Page/Page column 161
(2017/01/02)
QUINAZOLINE LINKED HETEROAROMATIC TRICYCLE DERIVATIVES AS PDE10A ENZYME INHIBITORS
This invention is directed to compounds of formula I which are PDE10A enzyme inhibitors, pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier and processes for th
-
Page/Page column 29
(2013/04/13)
Imidazole derivatives as PDE10A enzyme inhibitors
This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The pr
-
Page/Page column 12
(2012/06/01)
More Articles about upstream products of 635723-84-1